Page last updated: 2024-08-21

hydrazine and Thrombophilia

hydrazine has been researched along with Thrombophilia in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (75.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Fijnheer, R; Huisman, A; Koene, HR; Poolen, GC; Schutgens, REG; Thielen, N; Urbanus, RT; van Bladel, ER; van Dijk, WEM; van Galen, KPM1
Balduini, CL; Pecci, A; Rodeghiero, F1
Barcellini, W; Cantoni, S; Caparrotti, G; Carpenedo, M; Carrai, V; Crea, E; Di Nicola, M; Di Renzo, N; Fanin, R; Ferla, V; Liberati, AM; Paoloni, F; Santoro, C; Simonetti, F; Tuniz, E; Veneri, D; Volpetti, S; Zaja, F1
Barsam, S; Bussel, JB; Ghanima, W; Lee, SY; Miller, A; Sandset, PM1

Reviews

1 review(s) available for hydrazine and Thrombophilia

ArticleYear
Thrombopoietin receptor agonists in hereditary thrombocytopenias.
    Journal of thrombosis and haemostasis : JTH, 2018, Volume: 16, Issue:9

    Topics: Benzoates; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Genetic Association Studies; Genetic Heterogeneity; Genetic Predisposition to Disease; Hematologic Neoplasms; Humans; Hydrazines; Primary Myelofibrosis; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Risk; Thrombocytopenia; Thrombophilia; Thrombopoiesis; Thrombopoietin

2018

Other Studies

3 other study(ies) available for hydrazine and Thrombophilia

ArticleYear
Evaluation of the procoagulant state in chronic immune thrombocytopenia before and after eltrombopag treatment-a prospective cohort study.
    Journal of thrombosis and haemostasis : JTH, 2023, Volume: 21, Issue:4

    Topics: Adult; Factor VIII; Humans; Hydrazines; Prospective Studies; Purpura, Thrombocytopenic, Idiopathic; Thrombin; Thrombocytopenia; Thrombophilia; von Willebrand Factor

2023
Thrombopoietin receptor agonists for preparing adult patients with immune thrombocytopenia to splenectomy: results of a retrospective, observational GIMEMA study.
    American journal of hematology, 2016, Volume: 91, Issue:5

    Topics: Adrenal Cortex Hormones; Adult; Aged; Aged, 80 and over; Benzoates; Combined Modality Therapy; Drug Resistance; Female; Humans; Hydrazines; Immunoglobulins, Intravenous; Italy; Male; Middle Aged; Platelet Count; Portal Vein; Postoperative Complications; Premedication; Preoperative Care; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Salvage Therapy; Splenectomy; Thrombophilia; Thrombopoiesis; Thrombopoietin; Venous Thrombosis; Young Adult

2016
Venous thromboembolism and coagulation activity in patients with immune thrombocytopenia treated with thrombopoietin receptor agonists.
    British journal of haematology, 2012, Volume: 158, Issue:6

    Topics: Benzoates; Blood Coagulation; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Fibrin Fibrinogen Degradation Products; Fibrinolysis; Hemorrhage; Humans; Hydrazines; Platelet Count; Pulmonary Embolism; Purpura, Thrombocytopenic, Idiopathic; Pyrazoles; Receptors, Fc; Receptors, Thrombopoietin; Recombinant Fusion Proteins; Retrospective Studies; Thrombophilia; Thrombopoietin; Venous Thrombosis

2012